| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1015252027 |
| P356 | DOI | 10.1186/1471-230X-14-39 |
| P932 | PMC publication ID | 3942781 |
| P698 | PubMed publication ID | 24559185 |
| P2093 | author name string | Li Zhang | |
| Wei Wang | |||
| Hui Sun | |||
| Meng Li | |||
| Wei Cao | |||
| Jian Gao | |||
| Ya-Dong Wang | |||
| Chuan Shen | |||
| Ru Ji | |||
| Cai-Yan Zhao | |||
| Wei-Yan Yu | |||
| P2860 | cites work | Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity. | Q51694929 |
| Adipokines and cytokines in non-alcoholic fatty liver disease | Q80203451 | ||
| Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance | Q80310253 | ||
| Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies | Q80594561 | ||
| Resistin, an adipokine with potent proinflammatory properties | Q81672242 | ||
| Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin | Q82639139 | ||
| [Role of resistin in inflammation of hepatocytes in nonalcoholic steatohepatitis] | Q84591999 | ||
| Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
| Peroxisome proliferator activated receptor-gamma in pathogenesis of experimental fatty liver disease | Q33202380 | ||
| PTEN expression is down-regulated in liver tissues of rats with hepatic fibrosis induced by biliary stenosis | Q33496299 | ||
| Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions | Q33731663 | ||
| Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans | Q34092732 | ||
| Serum Resistin (FIZZ3) Protein Is Increased in Obese Humans | Q34275027 | ||
| Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes | Q34285331 | ||
| Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. | Q34525065 | ||
| Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells | Q35569812 | ||
| Pathological features of NASH. | Q36071709 | ||
| Nonalcoholic fatty liver disease: from steatosis to cirrhosis | Q36382279 | ||
| Obesity and the role of adipose tissue in inflammation and metabolism | Q36392619 | ||
| The role of resistin in obesity-induced insulin resistance | Q36453974 | ||
| Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease | Q36983514 | ||
| Non alcoholic fatty liver disease and metabolic syndrome. | Q37078311 | ||
| Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases | Q37141253 | ||
| Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production | Q39740973 | ||
| Conditioned medium obtained from in vitro differentiated adipocytes and resistin induce insulin resistance in human hepatocytes. | Q40090062 | ||
| High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians | Q40514603 | ||
| Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. | Q43494872 | ||
| Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators | Q44263788 | ||
| Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. | Q44527604 | ||
| Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients | Q44561660 | ||
| Abnormal glucose homeostasis due to chronic hyperresistinemia | Q44931180 | ||
| Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels | Q46090285 | ||
| Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis | Q46524814 | ||
| Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. | Q46880188 | ||
| Resistin is more abundant in liver than adipose tissue and is not up-regulated by lipopolysaccharide | Q47766113 | ||
| Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. | Q51492450 | ||
| P921 | main subject | inflammation | Q101991 |
| steatohepatitis | Q2335423 | ||
| overexpression | Q61643320 | ||
| P304 | page(s) | 39 | |
| P577 | publication date | 2014-02-23 | |
| P1433 | published in | BMC Gastroenterology | Q15759922 |
| P1476 | title | The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis | |
| P478 | volume | 14 |
| Q38346026 | Adipocytokines and hepatic fibrosis |
| Q39404643 | Adipokines in Liver Cirrhosis |
| Q36551969 | Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver |
| Q55379918 | Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease. |
| Q64055244 | Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis |
| Q64107807 | Dietary Eriodictyol Alleviates Adiposity, Hepatic Steatosis, Insulin Resistance, and Inflammation in Diet-Induced Obese Mice |
| Q28073402 | From Placenta to Polycystic Ovarian Syndrome: The Role of Adipokines |
| Q48168781 | Increased expression of resistin in ectopic endometrial tissue of women with endometriosis. |
| Q28067490 | Metabolic aspects of adult patients with nonalcoholic fatty liver disease |
| Q36566846 | Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines |
| Q38665591 | Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines |
| Q88241247 | Resistin Levels in Non-alcoholic Fatty Liver Disease Pathogenesis |
| Q90911092 | Resistin expression in human monocytes is controlled by two linked promoter SNPs mediating NFKB p50/p50 binding and C-methylation |
| Q33851911 | Seabuckthorn Leaves Extract and Flavonoid Glycosides Extract from Seabuckthorn Leaves Ameliorates Adiposity, Hepatic Steatosis, Insulin Resistance, and Inflammation in Diet-Induced Obesity |
| Q34547578 | Serum resistin levels may be new prognostic factor of crimean-congo hemorrhagic fever |
| Q37001197 | The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease |
| Q89110155 | Underrated enemy - from nonalcoholic fatty liver disease to cancers of the gastrointestinal tract |
Search more.